Synthetic carbohydrate-based HIV-1 vaccines
- 29 October 2020
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Technologies
- Vol. 35-36, 45-56
- https://doi.org/10.1016/j.ddtec.2020.09.004
Abstract
No abstract availableKeywords
Funding Information
- European Research Council (ERC-2016-STG-716878)
- Spanish Ministry of Science, Innovation and Universities (CTQ2017-87530-R, RYC-2015-17888, SEV-2016-0644)
This publication has 77 references indexed in Scilit:
- Broadly neutralizing antibodies and vaccine design against HIV-1 infectionFrontiers of Medicine, 2019
- Multiple roles for HIV broadly neutralizing antibodiesScience Translational Medicine, 2019
- Protein and Glycan Mimicry in HIV Vaccine DesignJournal of Molecular Biology, 2019
- Targeting Glycans of HIV Envelope Glycoproteins for Vaccine DesignPublished by Royal Society of Chemistry (RSC) ,2017
- Immune correlates of vaccine protection against HIV-1 acquisitionScience Translational Medicine, 2015
- Antibody responses to envelope glycoproteins in HIV-1 infectionNature Immunology, 2015
- Host Controls of HIV Neutralizing AntibodiesScience, 2014
- Synthetic carbohydrate antigens for HIV vaccine designCurrent Opinion in Chemical Biology, 2013
- Novel approaches in polyepitope T-cell vaccine development against HIV-1Expert Review of Vaccines, 2013
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandThe New England Journal of Medicine, 2009